MDxHealth S.A.
MDXH
Peringkat dalam Saham
#21738
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Harga Saham
$3.39
Terakhir disinkronkan: 2023-12-15
Kapitalisasi Pasar
$96.16M
Perubahan (1 hari)
-1.73%
Perubahan (1 tahun)
0.01%
Negara
BE
Perdagangan MDxHealth S.A. (MDXH)
Kategori
Healthcare
Riwayat pemecahan saham untuk MDxHealth S.A. (MDXH)
Saham MDxHealth S.A. (simbol: MDXH) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham MDXH yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham MDXH.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham MDXH yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham MDXH.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
